News

Pharmaceutical Technology on MSN4d
Eli Lilly sues Mochi Health and others for ‘deceptive’ tirzepatide marketing
Mochi Health Corp, Fella Health and Delilah, Willow Health Services, and Henry Meds are the named companies in Eli Lilly’s ...
Eli Lilly Files Slew of Lawsuits Over Zepbound and Mounjaro
Eli Lilly alleges Willow falsely claims its products are safe, effective and superior to its FDA-approved tirzepatide medicines, sold under Lilly's brand names: Mounjaro, which treats diabetes, and ...
Fierce Pharma4d
Texas outsourcer in Lilly's compounded tirzepatide lawsuit hit with FDA warning letter
A Houston-based compounding pharmacy that was recently roped into Eli Lilly’s fight against knockoff GLP-1s has landed in the ...
Devdiscourse5d
Eli Lilly Intensifies Legal Battle Over Tirzepatide Knockoff Sales
Eli Lilly escalates its crackdown on unauthorized tirzepatide copies, filing lawsuits against four compounders accused of ...
Analysts Maintain Buy Ratings on Eli Lilly Stock (LLY) as Q1 Earnings Loom
Eli Lilly (LLY) is scheduled to release its Q1 earnings on May 1, and analysts continue to stay positive, holding onto Buy ...
Eli Lilly and Company (LLY): Among Billionaire Ken Fisher’s Healthcare Stock Picks with Massive Upside Potential
We recently published a list of Billionaire Ken Fisher’s 10 Healthcare Stock Picks with Massive Upside Potential. In this ...
Eli Lilly Positioned To Dominate Obesity Market With Oral Option, Analyst Initiates With Confidence
Eli Lilly gains analyst support after Phase 3 success. Bullish forecasts for obesity dominance and key earnings are set for ...
Healio6d
Long-term weight regain minimal with tirzepatide for adults with obesity, prediabetes
Adults with overweight or obesity plus prediabetes maintain most of their weight loss with tirzepatide at more than 3 years, ...